A comprehensive view of hospital/clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

3rd Circuit Court sides with 340B drugmakers in contract pharmacy case; Court states drugmakers that participate in 340B drug pricing program do not have to provide discounted 340B drugs to unlimited number of contract pharmacies

Study finds OTC aspirin is as effective as injectable blood thinner to prevent blood clots in patients hospitalized with fractures; CDC reports blood clots cause up to 100,000 deaths in US each year; University of Maryland School of Medicine

Bristol Myers Squibb reports European Medicines Agency’s Committee for Medicinal Products for Human Use recommends approval of Reblozyl luspatercept to treat adult patients with anemia associated with non-transfusion-dependent beta thalassemia

US Senator Elizabeth Warren asks FTC to look into Amgen’s US$28.0B bid to buy Horizon Therapeutics, Indivior’s US$145.0M offer to buy Opiant; Warren cites potential drug affordability and access issues, 'rampant consolidation’ in pharma industry

FDA approves Merck’s Keytruda injectable as adjuvant treatment following surgical resection and platinum-based chemotherapy for patients with Stage IB, II, or IIIA non-small cell lung cancer; 2.2 million cases of lung cancer diagnosed in 2020

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count